REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
42 hedge funds and large institutions have $3.52M invested in REVIVA PHARMA HLDGS INC in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 10 closing their positions.
2,404% more call options, than puts
Call options by funds: $576K | Put options by funds: $23K
0.8% less ownership
Funds ownership: 1.49% → 0.69% (-0.8%)
9% less funds holding
Funds holding: 46 → 42 (-4)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
35% less capital invested
Capital invested by funds: $5.44M → $3.52M (-$1.93M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$182K |
| 2 |
Jane Street
New York
|
+$97K |
| 3 |
Millennium Management
New York
|
+$94.8K |
| 4 |
Renaissance Technologies
New York
|
+$92K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.03M |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
-$697K |
| 3 |
6CM
683 Capital Management
New York
|
-$381K |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$97.1K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$72.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
51
Wolverine Asset Management
Chicago,
Illinois
| – | -$168 | -22 | Closed |
|
52
UBS Group
Zurich,
Switzerland
| – | -$76 | -10 | Closed |
|
RVPH Hedge Fund Activity: Q3 2025 in Review
42 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q3 2025, worth a combined $3.52M — down 35% from $5.44M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of RVPH and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, adding an estimated $182K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.03M sold.
- 42 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q3 2025, down from 46 in Q2 2025.
- Funds reported $3.52M of REVIVA PHARMA HLDGS INC stock for Q3 2025, down 35% quarter-over-quarter.
- 7 funds opened new REVIVA PHARMA HLDGS INC positions in Q3 2025 and 10 closed out, a net change of -3 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q3 2025 was Susquehanna International Group, an estimated $182K added.
- The largest REVIVA PHARMA HLDGS INC seller in Q3 2025 was Armistice Capital, an estimated $1.03M sold.
Based on aggregated 13F filings for Q3 2025.